Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary E Herman

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Neuroprotection (Chichester, England)|December 15, 2025
How pandemics reshape our brain: Common links and targets between long-haul COVID-19, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), oxidative stress, and neurodegenerationMary E Herman
Frontiers in Endocrinology|June 27, 2024
Gluco-regulation & type 2 diabetes: entrenched misconceptions updated to new governing principles for gold standard managementStanley S Schwartz, Mary E Herman
Managed Care Interface|February 7, 2002
Health economic considerations in the management of type 2 diabetesJon C Clouse, Mark Zitter, Mary E Herman
Postgraduate Medicine|May 24, 2016
Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy's safety profileStanley S Schwartz, Paul S Jellinger, Mary E Herman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 20, 2015
THE RATIONALE FOR USE OF INCRETINS IN THE MANAGEMENT OF NEW ONSET DIABETES AFTER TRANSPLANTATION (NODAT)Archana R Sadhu, Stanley S Schwartz, Mary E Herman
Postgraduate Medicine|August 18, 2019
Intersections and Clinical Translations of Diabetes Mellitus with Cancer Promotion, Progression and PrognosisStanley S Schwartz, Struan F A Grant, Mary E Herman
Cleveland Clinic Journal of Medicine|July 11, 2019
Type 2 diabetes: Evolving concepts and treatmentEden Miller, Richard B Aguilar, Mary E Herman, et al.
Neuroprotection (Chichester, England)|December 12, 2025
Beta cells to brain cells: The pivotal role of insulin and glucose metabolism in Alzheimer's diseaseStanley S Schwartz, Elizabeth M Rhea, William A Banks, et al.
Progress in Cardiovascular Diseases|September 30, 2017
Insulin Therapy Increases Cardiovascular Risk in Type 2 DiabetesMary E Herman, James H O'Keefe, David S H Bell, et al.
BMC Medicine|September 3, 2024
Advances and counterpoints in type 2 diabetes. What is ready for translation into real-world practice, ahead of the guidelinesStanley S Schwartz, Barbara E Corkey, James R Gavin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neuroprotection (Chichester, England)|December 15, 2025
How pandemics reshape our brain: Common links and targets between long-haul COVID-19, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), oxidative stress, and neurodegenerationMary E Herman
Frontiers in Endocrinology|June 27, 2024
Gluco-regulation & type 2 diabetes: entrenched misconceptions updated to new governing principles for gold standard managementStanley S Schwartz, Mary E Herman
Managed Care Interface|February 7, 2002
Health economic considerations in the management of type 2 diabetesJon C Clouse, Mark Zitter, Mary E Herman
Postgraduate Medicine|May 24, 2016
Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy's safety profileStanley S Schwartz, Paul S Jellinger, Mary E Herman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 20, 2015
THE RATIONALE FOR USE OF INCRETINS IN THE MANAGEMENT OF NEW ONSET DIABETES AFTER TRANSPLANTATION (NODAT)Archana R Sadhu, Stanley S Schwartz, Mary E Herman
Postgraduate Medicine|August 18, 2019
Intersections and Clinical Translations of Diabetes Mellitus with Cancer Promotion, Progression and PrognosisStanley S Schwartz, Struan F A Grant, Mary E Herman
Cleveland Clinic Journal of Medicine|July 11, 2019
Type 2 diabetes: Evolving concepts and treatmentEden Miller, Richard B Aguilar, Mary E Herman, et al.
Neuroprotection (Chichester, England)|December 12, 2025
Beta cells to brain cells: The pivotal role of insulin and glucose metabolism in Alzheimer's diseaseStanley S Schwartz, Elizabeth M Rhea, William A Banks, et al.
Progress in Cardiovascular Diseases|September 30, 2017
Insulin Therapy Increases Cardiovascular Risk in Type 2 DiabetesMary E Herman, James H O'Keefe, David S H Bell, et al.
BMC Medicine|September 3, 2024
Advances and counterpoints in type 2 diabetes. What is ready for translation into real-world practice, ahead of the guidelinesStanley S Schwartz, Barbara E Corkey, James R Gavin, et al.
Pageof 2